StockData
Septerna, Inc. logo

Septerna, Inc. (SEPN) stock

SEPNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 8/30163% above fair value
$39.45−0.57 (-1.42%)

Close on Nov 18, 2026Market cap $1.84BP/E –Yield –

Septerna net income

Net income is the profit left for shareholders after every expense, interest and tax.

Septerna's net income for the twelve months ending Sep 30, 2026 was -$59.00M. For fiscal 2025 it was -$48.88M.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$48.88M–
FY2024Dec 31, 2024-$71.80M-1817.7%
FY2023Dec 31, 2023$4.18M–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$26.59M-425.3%
Q2 FY2026Jun 30, 2026-$13.03M–
Q1 FY2026Mar 31, 2026-$8.64M–
Q4 FY2025Dec 31, 2025-$10.74M–
Q3 FY2025Sep 30, 2025$8.17M–
Q2 FY2025Jun 30, 2025-$24.84M–
Q1 FY2025Mar 31, 2025-$21.48M–
Q4 FY2024Dec 31, 2024-$20.67M-159.2%
Q3 FY2024Sep 30, 2024-$20.52M–
Q2 FY2024Jun 30, 2024-$16.51M–
Q1 FY2024Mar 31, 2024-$14.10M–
Q4 FY2023Dec 31, 2023$34.89M–
Q3 FY2023Sep 30, 2023-$10.95M–
Q2 FY2023Jun 30, 2023-$10.60M–
Q1 FY2023Mar 31, 2023-$9.17M–

More Septerna figures

See a number that looks wrong?